Jul 11, 2011 11:24AM Needham & Company Reiterates a 'Buy' on Micromet (MITI); Signs BiTE Agreement with Another Brand Name Collaborator with Robust Terms

Jun 23, 2011 08:02AM Needham & Company Maintains a 'Buy' on Micromet (MITI); Five Things We Like About Micromet – Summary of Company Visit and Management Discussion

Jun 13, 2011 08:09AM Needham & Company Maintains a 'Buy' on Micromet (MITI); Data Strongly Support Pivotal Testing in 2012

May 19, 2011 07:42AM Needham & Company Reiterates a 'Buy' on Micromet (MITI); Management Meeting Highlights – You Say JCO, I say EHA

Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference

Mar 4, 2011 08:45AM Needham & Company Maintains a 'Buy' on Micromet (MITI); Blinatumomab Marches on in ALL - Enrolling Pivotal Trial

Jan 5, 2011 08:13AM Needham & Company Reiterates a 'Buy' on Micromet (MITI); Pipeline Progress to Provide Potential Catalysts, And Solid Cash Position Noted

Sep 21, 2010 08:05AM Needham & Company Reiterates a 'Buy' on Micromet (MITI); Summer May be Ending, but Clinical Activity is Heating Up

Jun 8, 2010 02:46PM Micromet (MITI) Shares Dip Almost 5%; Needham & Company Summarizes ASCO Presentation

Apr 20, 2010 03:43PM UPDATE - Needham & Company Reiterated a 'Buy' on Micromet (MITI)

Apr 20, 2010 08:02AM Needham & Company Reiterates a 'Buy' on Micromet (MITI); Positive Data Presentations at AACR of BiTE Platform

Apr 9, 2010 08:03AM Needham & Company Reiterates a 'Buy' Rating on Micromet (MITI) After Meeting with Management

Mar 12, 2010 07:16AM Micromet (MITI) Prices 10M Common Offering at $7.00/Share

Jan 25, 2010 09:14AM Needham & Co Initiates Coverage on Micromet (MITI) with a Buy